We are improving our search experience. To check which content you have full access to, or for advanced search, go back to the old search.

Search

Please fill in this field.
Filters applied:

Search Results

Showing 61-80 of 10,000 results
  1. Vpr driving DNA methylation variation of CD4 + T cells in HIV-1 infection

    Background

    Despite the existence of available therapeutic interventions for HIV-1, this virus remains a significant global threat, leading to...

    Peipei Wang, Zhuoyue Meng, ... **feng Cai in Virology Journal
    Article Open access 26 April 2024
  2. Steady-state memory-phenotype conventional CD4+ T cells exacerbate autoimmune neuroinflammation in a bystander manner via the Bhlhe40/GM-CSF axis

    Memory-phenotype (MP) CD4 + T cells are a substantial population of conventional T cells that exist in steady-state mice, yet their immunological...

    Min-Ji Cho, Hong-Gyun Lee, ... Je-Min Choi in Experimental & Molecular Medicine
    Article Open access 01 May 2023
  3. Coculture of Human Dendritic and T Cells for the Study of Specific T Cell-Mediated Responses Against Food Allergens

    Dendritic cells (DCs) connect innate and adaptive immunity by sampling, capturing, processing, and presenting the allergen to distinct subsets of...
    Mónica Martínez-Blanco, David Menchén-Martínez, ... Daniel Lozano-Ojalvo in Food Allergens
    Protocol 2024
  4. Nano-optogenetic CAR-T Cell Immunotherapy

    Chimeric antigen receptor (CAR)-T cell immunotherapy emerges as an effective cancer treatment. However, significant safety concerns remain, such as...
    Nhung Thi Nguyen, Siyao Liu, ... Kai Huang in Cancer Immunotherapy
    Protocol 2024
  5. Functional Analysis of Foxp3 and Its Mutants by Retroviral Transduction of Murine Primary CD4+ T Cells

    The transcription factor Foxp3/FOXP3 orchestrates regulatory T (Treg) cell development and function by interacting with numerous target genes and...
    Akira Nakajima, Ryuichi Murakami, Shohei Hori in Regulatory T-Cells
    Protocol 2023
  6. How autoreactive thymocytes differentiate into regulatory versus effector CD4+ T cells after avoiding clonal deletion

    Thymocytes bearing autoreactive T cell receptors (TCRs) are agonist-signaled by TCR/co-stimulatory molecules to either undergo clonal deletion or to...

    Xuguang Tai, Alyssa Indart, ... Alfred Singer in Nature Immunology
    Article Open access 23 March 2023
  7. Identification of human exTreg cells as CD16+CD56+ cytotoxic CD4+ T cells

    In atherosclerosis, some regulatory T (T reg ) cells become exT reg cells. We crossed inducible T reg and exT reg cell lineage-tracker mice ( FoxP3 eGFP−Cre-ERT2...

    Antoine Freuchet, Payel Roy, ... Klaus Ley in Nature Immunology
    Article 10 August 2023
  8. Multiparameter Flow Cytometry Monitoring of T Cell Responses

    Multiparameter flow cytometry is a common tool for assessing responses of T, B, and other cells to pathogens or vaccines. Such responses are likely...
    Holden T. Maecker in HIV Protocols
    Protocol 2024
  9. Immune checkpoints are predominantly co-expressed by clonally expanded CD4+FoxP3+ intratumoral T-cells in primary human cancers

    Background

    In addition to anti-PD(L)1, anti-CTLA-4 and anti-LAG-3, novel immune checkpoint proteins (ICP)-targeted antibodies have recently failed to...

    Delphine Bredel, Edi Tihic, ... Mélodie Bonvalet in Journal of Experimental & Clinical Cancer Research
    Article Open access 06 December 2023
  10. Intestinal helminth infection transforms the CD4+ T cell composition of the skin

    Intestinal helminth parasites can alter immune responses to vaccines, other infections, allergens and autoantigens, implying effects on host immune...

    Cajsa H. Classon, Muzhen Li, ... Susanne Nylén in Mucosal Immunology
    Article Open access 20 December 2021
  11. The gene expression profile and cell of origin of canine peripheral T-cell lymphoma

    Background

    Peripheral T-cell lymphoma (PTCL) refers to a heterogenous group of T-cell neoplasms with poor treatment responses and survival times....

    Eileen Owens, Lauren Harris, ... Anne Avery in BMC Cancer
    Article Open access 02 January 2024
  12. Dual T-cell constant β chain (TRBC)1 and TRBC2 staining for the identification of T-cell neoplasms by flow cytometry

    The diagnosis of leukemic T-cell malignancies is often challenging, due to overlap** features with reactive T-cells and limitations of currently...

    Pedro Horna, Matthew J. Weybright, ... Horatiu Olteanu in Blood Cancer Journal
    Article Open access 29 February 2024
  13. How to Test Human CAR T Cells in Solid Tumors, the Next Frontier of CAR T Cell Therapy

    Chimeric antigen receptor (CAR) T cell therapy has proven to be a successful treatment option for leukemias and lymphomas. These encouraging outcomes...
    Russell W. Cochrane, Andrew Fiorentino, ... Leonardo M. R. Ferreira in Cancer Immunotherapy
    Protocol 2024
  14. Genetic Modification of Tumor-Infiltrating Lymphocytes, Peripheral T Cells, and T-Cell Model Cell Lines

    Genetic modification of tumor-infiltrating lymphocytes (TILs) or circulating T cells has become an important avenue in cancer therapy. Here we...
    Hadas Weinstein-Marom, Dayana Blokon-Kogan, ... Lior Nissim in Cancer Immunotherapy
    Protocol 2024
  15. Phenotypic and Functional Characterization of Memory CD4+ and CD8+ T Cells After Antigenic Stimulation

    The encounter of T cells with the antigen through the interaction of T cell receptors with peptides and major histocompatibility complex (MHC)...
    Carolina do Prado Servian, Letícia Carrijo Masson, Simone Gonçalves Fonseca in Immune Homeostasis
    Protocol 2024
  16. Self-adjuvanting nanovaccines boost lung-resident CD4+ T cell immune responses in BCG-primed mice

    Heterologous vaccine regimens could extend waning protection in the global population immunized with Mycobacterium bovis Bacille Calmette-Guerin...

    Megan A. Files, Kubra F. Naqvi, ... Janice J. Endsley in npj Vaccines
    Article Open access 26 April 2022
  17. Associations of different immune checkpoints-expressing CD4+ Treg/ T cell subsets with disease-free survival in colorectal cancer patients

    There are different subsets of T regulatory cells (Tregs), orchestrating critical roles in the regulation of anti-tumor immunity in colorectal cancer...

    Mohammad A. Al-Mterin, Khaled Murshed, ... Eyad Elkord in BMC Cancer
    Article Open access 02 June 2022
  18. Characterization of HIV variants from paired Cerebrospinal fluid and Plasma samples in primary microglia and CD4+ T-cells

    Despite antiretroviral therapy (ART), HIV persistence in the central nervous system (CNS) continues to cause a range of cognitive impairments in...

    Stephanie B. H. Gumbs, Arjen J. Stam, ... Monique Nijhuis in Journal of NeuroVirology
    Article Open access 07 May 2024
  19. Control of CD4+ T Cell Differentiation and Function by PI3K Isoforms

    The phosphoinositide-3-kinase (PI3K) pathway is a highly conserved intracellular signaling pathway involving numerous key effectors which, in...
    Benjamin Cameron, Syed Aymaan Zaheer, Margarita Dominguez-Villar in PI3K and AKT Isoforms in Immunity
    Chapter 2022
  20. Potential clinical implications of CD4+CD26high T cells for nivolumab treated melanoma patients

    Background

    Nivolumab is an anti-PD1 antibody that has dramatically improved metastatic melanoma patients’ outcomes. Nevertheless, many patients are...

    Domenico Galati, Serena Zanotta, ... Paolo A. Ascierto in Journal of Translational Medicine
    Article Open access 11 May 2023
Did you find what you were looking for? Share feedback.